ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
0,00%
Bitcoin
66.566,70
0,57%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) News

NVAX

Novavax (NVAX)

Novavax Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NVAX
DatumZeitQuelleÜberschriftSymbolFirma
14/06/202422h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/06/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/06/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/06/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/06/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/06/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/06/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
14/06/202420h05PR Newswire (US)Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 VaccineNASDAQ:NVAXNovavax Inc
06/06/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
05/06/202403h35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
30/05/202415h25PR Newswire (US)Novavax to Participate in 2024 Jefferies Global Healthcare ConferenceNASDAQ:NVAXNovavax Inc
23/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
20/05/202420h42Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
20/05/202412h35GlobeNewswire Inc.Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual MeetingNASDAQ:NVAXNovavax Inc
20/05/202412h09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NVAXNovavax Inc
16/05/202403h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/05/202423h02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVAXNovavax Inc
13/05/202422h10Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
13/05/202422h02PR Newswire (US)Novavax to Participate in BofA Securities 2024 Health Care ConferenceNASDAQ:NVAXNovavax Inc
13/05/202420h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
10/05/202414h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
10/05/202414h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
10/05/202414h02IH Market NewsNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More NewsNASDAQ:NVAXNovavax Inc
10/05/202408h15PR Newswire (US)Novavax Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
10/05/202408h00PR Newswire (US)Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesNASDAQ:NVAXNovavax Inc
08/05/202422h53Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
07/05/202423h21Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
07/05/202420h43Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NVAXNovavax Inc
07/05/202415h25PR Newswire (US)Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024NASDAQ:NVAXNovavax Inc
 Showing the most relevant articles for your search:NASDAQ:NVAX

Kürzlich von Ihnen besucht

NYSE
MRK
Merck
CCOM
US100
US Tech 100
FX
EURUSD
Euro vs US Dollar
COIN
ETHUSD
Ethereum
TG
TUI1
Tui
TG
CBK
Commerzbank
USOTC
RHHBY
Roche (QX)
TG
ALV
Allianz
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
SILVER
SILVER
NASDAQ
GOOGL
Alphabet
COIN
SOLUSD
Solana
FX
EURGBP
Euro vs Sterling
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten